NCT04871477

Brief Summary

This study evaluates how patients feel about having an audio recording of their visit to help remember information given to them and share that information with family members and/or caregivers not present during a clinic visit. Information from this study may help evaluate the effectiveness of using technology to help improve patient care by recording consultation recommendations.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
9mo left

Started Jan 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Jan 2026Jan 2027

First Submitted

Initial submission to the registry

April 5, 2021

Completed
29 days until next milestone

First Posted

Study publicly available on registry

May 4, 2021

Completed
4.7 years until next milestone

Study Start

First participant enrolled

January 30, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2027

Last Updated

January 14, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

April 5, 2021

Last Update Submit

January 13, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Proportion of patients who will select "Complete Agree/Partially Agree" in Question 1 "I found the audio recording useful after the visit"

    Will be summarized using proportion along with a 95% confidence interval.

    through study completion, an average of 1 year

  • Proportion of patients who will select "Complete Agree/Partially Agree" in Question 2 "I was able to effectively discuss my medical condition with my family member(s) and/or caregiver(s) who were not present at the clinical visit

    Will be summarized using proportion along with a 95% confidence interval.

    through study completion, an average of 1 year

Secondary Outcomes (7)

  • Number of times the recording is listened to

    through study completion, an average of 1 year

  • To assess the ease of use of the technology.

    through study completion, an average of 1 year

  • To assess the ability to share the information with the patient's family member(s) and/or caregiver(s) if he or she chooses to do so.

    through study completion, an average of 1 year

  • To assess the patient perception of whether the audio recording caused any disruption to the clinic

    through study completion, an average of 1 year

  • Patient participation rate

    through study completion, an average of 1 year

  • +2 more secondary outcomes

Study Arms (1)

Observational (audio recording)

Patients audio record the recommendations and instructions given to them by the doctor record as part of their clinic visit at the Supportive Care Center.

Other: Communication InterventionOther: Questionnaire Administration

Interventions

Audio record part of clinic visit

Observational (audio recording)

Ancillary studies

Observational (audio recording)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with advanced cancer at MD Anderson Cancer Center.

You may qualify if:

  • Patients with the diagnosis of advanced cancer as defined as locally advanced, recurrent or metastatic cancer. Both solid and liquid tumors are eligible for the study
  • Patients who are seen in the outpatient supportive care center at M.D. Anderson Cancer Center
  • Patients who have access to a recording device or cellphone with recording technology
  • Patients who can be contacted 7 to 11 days from the clinic visit that the recording took place
  • Patients who can sign informed consent
  • Patients who are able to read and write in English
  • Patients 18 years or older

You may not qualify if:

  • Patients who have been diagnosed with delirium or cognitive impairment. This will be defined by chart review along with review of the MD Anderson Symptom Inventory (MDAS) the day of clinic visit. An MDAS of 7 or greater will be considered to define delirium in this study
  • Patients who are unwilling to sign informed consent
  • Patients who have used audio recordings before in clinic visits
  • Patients who have severe hearing impairments without access to assisted devices or programs to aid in listening to the recorded material

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M D Anderson Cancer Center

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Hematologic NeoplasmsNeoplasm Metastasis

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsHematologic DiseasesHemic and Lymphatic DiseasesNeoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael J Tang

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael Tang, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2021

First Posted

May 4, 2021

Study Start

January 30, 2026

Primary Completion (Estimated)

January 30, 2027

Study Completion (Estimated)

January 30, 2027

Last Updated

January 14, 2026

Record last verified: 2026-01

Locations